English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
International Foundation for Autoimmune
Patient Daily
| Dec 9, 2025
International Arthritis Foundation urges changes to 340B drug pricing program
Trending
+
Pharmaceuticals
Patient Daily
| Feb 3, 2026
Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+
Pharmaceuticals
Patient Daily
| Feb 2, 2026
Clinical trial landscape shifts globally as China increases role in innovation
+
Pharmaceuticals
Patient Daily
| Feb 5, 2026
FDA lifts hold on Intellia's phase III ATTR gene editing trial
+
Pharmaceuticals
Patient Daily
| Feb 4, 2026
Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor
